Search Results for "Mdx1106 Netherlands"
Original Source: A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies
To determine the safety and tolerability of MDX-1106 when administered to patients with advanced non-small cell lung cancer, colorectal cancer, malignant melanoma, renal clear cell cancer or hormone refractory prostate cancer
Matching Channels
uniQure has developed Glybera as a therapy for patients with the genetic disorder lipoprotein lipase deficiency. LPLD is an orphan disease for which no treatment exists today. The disease is caused...
Matching News
[Comment] Euthanasia in the Netherlands: what lessons for elsewhere?
The Netherlands is one of the few places in the world where euthanasia and physician-assisted suicide are legal under specific circumstances. In The Lancet, Bregje Onwuteaka-Philipsen and colleagues p...
PRA expands operations in the Netherlands and U.K.
PRA, a global CRO, is expanding its operations in the Netherlands and the U.K. to accommodate staff growth and strong client demand for its phase IIa-IIIb service offerings.
The Netherlands successful in European research and innovation
February 8, 2013 - The Netherlands maintains its strong position in European research and innovation.
Euthanasia and assisted suicide rates in the Netherlands comparable to rates before legalisation
2010 rates of euthanasia and assisted suicide in the Netherlands were comparable to levels before the practices were legalised in 2002, according to new research published Online First in The Lancet a...
Netherlands embracing generics to counter growing health care costs
With the elderly making up an ever greater share of the country's population, the Netherlands is increasingly supporting its generics sector in an attempt to address mounting healthcare costs, says a...
Sleep survey reveals that 78 percent of people suffering from sleep apnea are unaware of it
Philips Electronics today announced the results of an extensive new scientific study into sleep apnea, conducted over the last two years by Philips in collaboration with University of Twente (Enschede...
Life Tech takes over Netherlands-based protein purification products developer
Global biotechnology company Life Technologies has acquired Netherlands-based BAC BV which develops and manufactures protein purification products.
ROTTERDAM, Netherlands, June 27, 2012 /PRNewswire/ -- Data presented today from the Privigen Impact on Mobility and Autonomy (PRIMA) trial at the Peripheral Nerve Society Inflammatory Neuropathy Conso...
Matching PubMed Articles
Conflicts of interest: call for new editorial policies in European national journals.
Ablation for atrial fibrillation: CT overlay or standard electroanatomical mapping?
Myocardial perfusion imaging in coronary artery disease: SPECT, PET or CMR?
Women and men with stable coronary artery disease: different risk factors but similar outcomes!
Crown years for noninvasive cardiovascular imaging (part I): 60 years of echocardiography.
